liverRegression code.

liverRegression code.

<p dir="ltr">Enhancers are transcriptional regulatory elements that help drive phenotypic diversity, yet they often undergo rapid sequence evolution despite functional conservation, posing a challenge for predicting their function across species. Previous machine learning models have...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autor principal:	Amy Stephen (22684448) (author)
Publicat:	2025
Matèries:	Bioinformatic methods development Genomics and transcriptomics Convolutional Neural Networks. comparative genomics approaches
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

DeepEvo
per: Juntian Qi (22578974)
Publicat: (2025)

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

<b>Minimal repeats identified by machine learning as novel cross-species markers of translation initiation sites</b>
per: Ali Mohammad Ali Maddi (11301486)
Publicat: (2025)

Supplementary File 1 from Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
per: Rania Bassiouni (14963190)
Publicat: (2025)

Supplementary File 2 from Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
per: Rania Bassiouni (14963190)
Publicat: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Table S2 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
per: Elena Llano (14963220)
Publicat: (2025)

Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
per: Elena Llano (14963220)
Publicat: (2025)

Table S5 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
per: Elena Llano (14963220)
Publicat: (2025)

table s1 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
per: Elena Llano (14963220)
Publicat: (2025)

table s4 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
per: Elena Llano (14963220)
Publicat: (2025)

Data Sheet 1_Genome-wide identification and expression profiling of bHLH transcription factors associated with ferulic acid biosynthesis in Angelica sinensis.zip
per: Khadija Tehseen Arshad (22687526)
Publicat: (2025)

Table 1_Genome-wide identification and expression profiling of bHLH transcription factors associated with ferulic acid biosynthesis in Angelica sinensis.xlsx
per: Khadija Tehseen Arshad (22687526)
Publicat: (2025)

scRNA-seq, Oligodendrocyte-Lineage Meta-Atlas
per: Nicholas Mikolajewicz (11242755)
Publicat: (2025)

基于机器学习和网络药理学分析类风湿关节炎中大麻二酚治疗双靶点机制
per: xiaohua fang (22678832)
Publicat: (2025)

Structural variants of <i>Fragaria vesca</i>
per: Minto Odagiri (22680003)
Publicat: (2025)

Gene expression data of <i>Fragaria vesca</i>
per: Minto Odagiri (22680003)
Publicat: (2025)

Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
per: Dhruv Chachad (14954640)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_a1hm9mfc94o38k0httmr7sqktv